BMY
Bristol-Myers Squibb
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BMY
- PEG Ratio
Bristol-Myers Squibb is trading with a PEG ratio of 0.26, based on Nov 11, 2026 data. Dividing the 13.89 PE ratio by the 52.5% earnings growth rate yields this valuation metric. Relative to the 0.25 average from the previous four quarters, the PEG ratio has grown by 3%.
BMY PEG ratio history
Historically, Bristol-Myers Squibb shows a PEG ratio averaging 0.26 across the past ten years. Today's 0.26 PE to growth ratio aligns closely with its historical average. The ten years high occurred in the Mar 2023 quarter at 0.92, reflecting maximum valuation relative to growth. The minimum was hit in the Jun 2019 quarter at 0.01, indicating optimal value relative to growth during that period.
Bristol-Myers Squibb PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.09 | 15.54 | 178.7% |
| 2024 | N/A | N/A | -213.7% |
| 2023 | 0.43 | 13.22 | 30.6% |
| 2022 | N/A | 24.23 | -5.7% |
| 2021 | 0.11 | 19.79 | 178.9% |
| 2020 | N/A | N/A | -297.5% |
| 2019 | N/A | 31.78 | -32.9% |
| 2018 | 0.04 | 17.27 | 393.4% |
| 2017 | N/A | 100.46 | -77.2% |
| 2016 | 0.12 | 21.89 | 184% |
| 2015 | N/A | 73.18 | -22.3% |
| 2014 | N/A | 48.79 | -22.4% |
| 2013 | 1.02 | 34.07 | 33.3% |
| 2012 | N/A | 27.85 | -46.3% |
| 2011 | 0.77 | 16.17 | 21.1% |
Bristol-Myers Squibb PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Sep 2026 | 0.26 | 13.77 | 52.5% |
| Jun 2026 | 0.15 | 12.66 | 82.7% |
| Mar 2026 | 0.51 | 16.99 | 33.2% |
| Dec 2025 | 0.09 | 15.54 | 178.7% |
| Sep 2025 | 0.08 | 15.19 | 182.7% |
| Jun 2025 | 0.11 | 18.59 | 176.6% |
| Mar 2025 | 0.12 | 22.76 | 186.7% |
| Dec 2024 | N/A | N/A | -213.7% |
| Sep 2024 | N/A | N/A | -190.4% |
| Jun 2024 | N/A | N/A | -186% |
| Mar 2024 | N/A | N/A | -189.3% |
| Dec 2023 | 0.43 | 13.22 | 30.6% |
| Sep 2023 | 0.51 | 14.62 | 28.5% |
| Jun 2023 | 0.7 | 16.92 | 24.3% |
| Mar 2023 | 0.92 | 20.03 | 21.8% |
BMY average PEG ratio chart
Measured against past performance, BMY's PEG ratio is higher than its 3-year average, though it is below the 5-year average.
PEG comparison
With a PEG of 0.26, BMY is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 0.62, Bristol-Myers Squibb's PEG is 58% lower.
BMY EPS growth
BMY Price vs fair value
BMY PEG vs peers
Compared to its peers, BMY's PEG ratio is under LLY's and AZN's but above ABBV's. Bristol-Myers Squibb's PEG ratio of 0.26 is below the peer average of 0.85.
Frequently asked questions
What is Bristol-Myers Squibb's PEG ratio?
BMY's Nov 11, 2026 PEG ratio comes in at 0.26.
What is the 3-year average PEG ratio for Bristol-Myers Squibb (BMY)?
BMY has a 3-year average PEG ratio of 0.22.
What is the 5-year average PEG ratio for Bristol-Myers Squibb (BMY)?
BMY has a 5-year average PEG ratio of 0.29.
What is the highest PEG ratio for BMY?
In the last ten years, BMY's peak PEG ratio of 0.92 was recorded in the Mar 2023 quarter.
How does the current PEG ratio for BMY compare to its historical average?
BMY's PEG ratio equals its 10-year historical average.
Why is Bristol-Myers Squibb's PEG ratio so low?
Strong earnings growth relative to valuation produces BMY's low PEG ratio of 0.26.
How is BMY's PEG ratio calculated (Bristol-Myers Squibb PEG ratio formula)?
The PEG ratio comes from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Nov 11, 2026, Bristol-Myers Squibb has a P/E ratio of 13.89. Earnings grew at 52.5% over the TTM period ending Sep 2026. Applying the formula, this produces a price to earnings growth ratio of 0.26. PEG RATIO(0.26) = PE RATIO(13.89) / EPS GROWTH(52.5%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.